There are currently 959 clinical trials in Birmingham, Alabama looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Alabama at Birmingham, University of Alabama, University of Alabama at Birmingham Cancer Center and University of Alabama-Birmingham. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Novel Dental Gel as an Adjunct to Scaling and Root Planing
Recruiting
This study will evaluate the use of Livionex Dental Gel (LDG) as a home care product in reducing probing pocket depth (PD) beyond the effect achieved by the current standard of care with SRP in periodontitis patients.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
10/03/2024
Locations: Unversity of Alabama at Birmingham, School of Dentistry, Birmingham, Alabama
Conditions: Periodontal Diseases, Gingival Diseases, Gingival Pocket, Gum Bleed, Plaque, Dental
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Recruiting
The main purpose of this study is to assess the efficacy and safety of volrustomig compared to observation in participants with unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) who have not progressed after receiving definitive concurrent chemoradiotherapy (cCRT).
Gender:
ALL
Ages:
Between 18 years and 130 years
Trial Updated:
10/02/2024
Locations: Research Site, Birmingham, Alabama
Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma
The PediQUEST Response to Pain Of Children With Neurologic Disability Pilot Randomized Controlled Trial
Recruiting
The goal of this pilot randomized controlled trial is to test the feasibility of running a full scale randomized controlled trial that compares the effect of the PQ-ResPOND intervention versus usual care to improve recurrent pain in children, adolescents, and young adults with severe neurologic impairment. The main questions it aims to answer are: * Is the study feasible and acceptable for participants? * Does PQ-ResPOND have a potential to be effective? Participants will: * answer surveys (t... Read More
Gender:
ALL
Ages:
1 year and above
Trial Updated:
10/01/2024
Locations: University of Alabama, Birmingham, Birmingham, Alabama
Conditions: Cerebral Palsy Infantile, Disabilities Multiple, Pain
Olorofim Aspergillus Infection Study
Recruiting
The purpose of this study is to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with IFD caused by proven IA or probable lower respiratory tract disease Aspergillus species (invasive aspergillosis, IA).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/26/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Invasive Aspergillosis
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Recruiting
The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 narcolepsy, who were exposed to previously tested doses of TAK-861.
Gender:
ALL
Ages:
Between 16 years and 70 years
Trial Updated:
09/24/2024
Locations: Sleep Disorders Center of Alabama, Birmingham, Alabama
Conditions: Narcolepsy Type 1
Neuroblastoma Maintenance Therapy Trial
Recruiting
Difluoromethylornithine (DFMO) will be used in an open label, single agent, multicenter, study for patients with neuroblastoma in remission. In this study subjects will receive 730 Days of oral difluoromethylornithine (DFMO) at a dose of 750 mg/m2 ± 250 mg/m2 BID (strata 1, 2, 3, and 4) OR 2500 mg/m2 BID (stratum 1B) on each day of study. This study will focus on the use of DFMO in high risk neuroblastoma patients that are in remission as a strategy to prevent recurrence.
Gender:
ALL
Ages:
Between 1 year and 30 years
Trial Updated:
09/18/2024
Locations: University of Alabama, Children's of Alabama, Birmingham, Alabama
Conditions: Neuroblastoma
Monitoring Blood Pressure at Home
Recruiting
The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage your blood pressure is feasible. The study will enroll 24 participants at UAB who are seen at the Emergency Department Post-Discharge Clinic. Half of the participants (12 patients) will be asked to measure their blood pressure at home, and half of the participants (12 patients) will continue to receive usual care. Participants who measure... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/18/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Hypertension
Investigating the Use of TaVNS to Treat Insomnia in Individuals with Breast Cancer (taVNS-insomnia-BC)
Recruiting
In the present study, the investigators aim to investigate feasibility of utilizing noninvasive neuromodulation, specifically taVNS, as a nonpharmacologic approach to address insomnia in patients with stage I-IV breast cancer.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
09/17/2024
Locations: UAB Lakeshore Collaborative (WHARF), Birmingham, Alabama +1 locations
Conditions: Breast Cancer, Insomnia
A Community Health Worker Intervention to Address Adverse Pregnancy Outcomes
Recruiting
United States maternal mortality and preterm birth rates are among the highest among high-income countries due in part to a combination of racial, regional and socioeconomic disparities in access to care and overall health. The research proposed focuses on adapting and expanding a perinatal community health worker intervention for Black postpartum patients with preeclampsia (PE) and other adverse pregnancy outcomes (APOs). Investigators will partner with a community-based organization that train... Read More
Gender:
FEMALE
Ages:
Between 16 years and 56 years
Trial Updated:
09/17/2024
Locations: UAB Medicine, Birmingham, Alabama +1 locations
Conditions: Preeclampsia Postpartum, Adverse Pregnancy Outcomes
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
Recruiting
This is an open label, single center, non-randomized dose de-escalation phase I study of combination of BV and Mogamulizumab. The primary objective of the study is to assess the safety and tolerability of the combination. The primary objective is also to explore safe dose of combination for future expansion.
Gender:
ALL
Ages:
19 years and above
Trial Updated:
09/16/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Cutaneous T Cell Lymphoma, Mycosis Fungoides
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies
Recruiting
SLS009 (formerly GFH009) is a potent and highly selective CDK9 inhibitor. In this study the safety, tolerability, and antitumor activity of single agent SLS009 are assessed in two dose escalation groups (Group 1 in patients with relapsed/refractory AML, Group 2 in patients with relapse/refractory lymphoma/CLL/SLL). The safety, tolerability, and antitumor activity of SLS009 in combination with venetoclax and azacitidine in patient with relapsed/refractory AML who have relapsed on or are refractor... Read More
Gender:
ALL
Ages:
12 years and above
Trial Updated:
09/11/2024
Locations: O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham, Alabama
Conditions: Hematologic Malignancies
Transferring Speed of Processing Gains to Everyday Cognitive Tasks After Stroke
Recruiting
This study will compare two approaches to cognitive rehabilitation in adults with stroke with persistent, mild to moderate, cognitive impairment. Both approaches will feature a web-based computer "game" that trains cognitive processing speed, i.e., how quickly individuals process information that they receive through their senses. This training is termed Speed of Processing Training (SOPT). One approach will add (A) in-lab training on everyday activities with important cognitive components and (... Read More
Gender:
ALL
Ages:
40 years and above
Trial Updated:
09/10/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Stroke, Cognitive Dysfunction